Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,011 | -47,782 | -36,390 | -19,232 | -55,466 |
| Depreciation Amortization | 65,055 | 11,371 | 1,287 | 604 | 2,239 |
| Income taxes - deferred | -17,244 | -3,610 | -3,657 | 47 | -104 |
| Accounts receivable | 545 | 815 | 1,816 | 1,144 | -1,199 |
| Other Working Capital | 2,450 | 5,306 | 4,202 | 47 | -366 |
| Other Operating Activity | -9,055 | 3,370 | 10,913 | 3,149 | 8,002 |
| Operating Cash Flow | $-39,258 | $-30,531 | $-21,827 | $-14,240 | $-46,895 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,984 | 1,653 | -3,013 | 7,049 | -7,130 |
| PPE Investments | -3,186 | -2,574 | 5,246 | -345 | -3,657 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 51 |
| Investing Cash Flow | $3,798 | $-921 | $2,233 | $6,705 | $-10,737 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 133 | 1,087 | 1,090 | 340 | 1,827 |
| Debt Repayment | N/A | N/A | 0 | 0 | 11,763 |
| Common Stock Issued | 36,471 | 36,137 | 36,136 | 7,412 | 18,702 |
| Other Financing Activity | 0 | -904 | -595 | -259 | -1,621 |
| Financing Cash Flow | $36,604 | $36,320 | $36,631 | $7,493 | $30,672 |
| Beginning Cash Position | 19,174 | 19,174 | 19,174 | 19,174 | 46,134 |
| End Cash Position | 20,318 | 24,043 | 36,211 | 19,131 | 19,174 |
| Net Cash Flow | $1,144 | $4,869 | $17,037 | $-43 | $-26,960 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,258 | -30,531 | -21,827 | -14,240 | -46,895 |
| Capital Expenditure | -3,186 | -2,574 | -1,803 | -345 | -3,657 |
| Free Cash Flow | -42,444 | -33,104 | -23,630 | -14,585 | -50,553 |